Medartis Keeps Pace with Priorities Amid COVID

Medartis reported 1H20 orthopedic revenue of CHF 57 million (USD $60.3 million), -11.6% vs. 1H19. Despite the impact of COVID, the company is forging ahead with its priorities of addressing regional management needs, expanding its U.S. business as well as accelerating its innovation pipeline.

Medartis appointed Lisa Thompson and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us